By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.

The funding for two million people to receive the twice-yearly preventative treatment lenacapavir is ‘receding in the chaos’ ...

A population-based study finds that nearly 15% of individuals using HIV preexposure prophylaxis are diagnosed with alcohol ...

The lack of funding is expected to set back decades' worth of progress against HIV, according to public health experts.

Mozambique ramps up inclusive HIV services as community group ensures people with disabilities get equitable access to ...

The S&P 500 index closed higher on Monday as investors were still optimistic over trade talks between the United States and ...

University of South Florida and Tampa General Hospital Cancer Institute launch the “Microbial Oncogenesis and Cancer Therapy” ...

Updated CDC guidelines on PEP after nonoccupational HIV exposure address newer ART agents and clinical considerations for patients with a history of long-acting ART.

The Los Angeles medical examiner has ruled Guerrero’s manner of death as natural, brought on by AIDS-related complications.

In Philippi village in the Western Cape of South Africa, 24-year-old Simamkele Matinise works at an HIV-prevention mobile ...